Wilmington Savings Fund Society’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Sell
47,244
-1,199
-2% -$410K 0.38% 60
2026
Q1
$17M Sell
48,443
-1,420
-3% -$506K 0.41% 59
2025
Q4
$16.3M Sell
49,863
-1,713
-3% -$543K 0.38% 61
2025
Q3
$14.6M Sell
51,576
-5,627
-10% -$1.63M 0.35% 67
2025
Q2
$16M Sell
57,203
-3,152
-5% -$893K 0.28% 72
2025
Q1
$18.8M Sell
60,355
-3,572
-6% -$1.05M 0.35% 61
2024
Q4
$16.7M Sell
63,927
-1,274
-2% -$378K 0.3% 66
2024
Q3
$21M Buy
65,201
+5,748
+10% +$1.88M 0.38% 60
2024
Q2
$18.6M Sell
59,453
-737
-1% -$217K 0.71% 37
2024
Q1
$17.1M Buy
+60,190
New +$17.6M 0.66% 41
2023
Q3
$16.6M Sell
61,632
-66
-0.1% -$16.5K 0.73% 35
2023
Q2
$13.7M Buy
61,698
+568
+0.9% +$132K 0.57% 44
2023
Q1
$14.8M Buy
61,130
+384
+0.6% +$94.3K 0.65% 39
2022
Q4
$16M Sell
60,746
-532
-0.9% -$143K 0.72% 37
2022
Q3
$13.8M Sell
61,278
-2,841
-4% -$689K 0.67% 33
2022
Q2
$15.6M Sell
64,119
-2,812
-4% -$689K 0.72% 35
2022
Q1
$16.2M Sell
66,931
-5,992
-8% -$1.38M 0.63% 41
2021
Q4
$16.4M Sell
72,923
-1,000
-1% -$211K 0.59% 45
2021
Q3
$15.7M Sell
73,923
-974
-1% -$224K 0.61% 44
2021
Q2
$18.3M Sell
74,897
-301
-0.4% -$74K 0.7% 36
2021
Q1
$18.7M Sell
75,198
-3,518
-4% -$839K 0.75% 33
2020
Q4
$18.1M Sell
78,716
-1,456
-2% -$336K 0.76% 35
2020
Q3
$20.4M Sell
80,172
-3,200
-4% -$793K 0.94% 29
2020
Q2
$19.7M Sell
83,372
-12,575
-13% -$2.87M 0.97% 30
2020
Q1
$19.5M Buy
95,947
+4,564
+5% +$997K 1.14% 20
2019
Q4
$22M Sell
91,383
-1,393
-2% -$307K 1.12% 22
2019
Q3
$18M Sell
92,776
-227
-0.2% -$43.6K 0.98% 28
2019
Q2
$17.1M Buy
93,003
+727
+0.8% +$130K 0.93% 29
2019
Q1
$17.5M Buy
92,276
+1,102
+1% +$210K 0.95% 30
2018
Q4
$17.7M Buy
91,174
+24,734
+37% +$4.83M 1.08% 23
2018
Q3
$13.8M Sell
66,440
-289
-0.4% -$57K 0.73% 40
2018
Q2
$12.3M Buy
66,729
+1,307
+2% +$231K 0.69% 43
2018
Q1
$11.2M Sell
65,422
-1,018
-2% -$187K 0.64% 48
2017
Q4
$11.6M Sell
66,440
-533
-0.8% -$94.3K 0.63% 48
2017
Q3
$12.5M Sell
66,973
-2,239
-3% -$397K 0.71% 41
2017
Q2
$11.9M Buy
69,212
+2,409
+4% +$392K 0.71% 44
2017
Q1
$11M Sell
66,803
-1,617
-2% -$269K 0.66% 44
2016
Q4
$10M Sell
68,420
-1,332
-2% -$200K 0.63% 47
2016
Q3
$11.6M Sell
69,752
-39,741
-36% -$6.72M 0.73% 43
2016
Q2
$16.7M Buy
109,493
+990
+0.9% +$154K 1.06% 27
2016
Q1
$16.3M Sell
108,503
-2,345
-2% -$348K 1.04% 27
2015
Q4
$18M Sell
110,848
-1,368
-1% -$215K 1.13% 22
2015
Q3
$15.5M Sell
112,216
-20,936
-16% -$3.3M 0.99% 25
2015
Q2
$20.4M Sell
133,152
-8,627
-6% -$1.38M 1.19% 18
2015
Q1
$22.7M Sell
141,779
-3,969
-3% -$625K 1.29% 15
2014
Q4
$23.2M Sell
145,748
-6,655
-4% -$1.04M 1.3% 16
2014
Q3
$21.4M Sell
152,403
-1,884
-1% -$246K 1.21% 19
2014
Q2
$18.3M Sell
154,287
-2,465
-2% -$285K 1.01% 26
2014
Q1
$19.3M Buy
156,752
+142
+0.1% +$17.2K 1.08% 22
2013
Q4
$17.9M Buy
156,610
+5,928
+4% +$674K 1.01% 25
2013
Q3
$16.9M Sell
150,682
-1,600
-1% -$173K 1.04% 24
2013
Q2
$15M Buy
+152,282
New +$15.8M 0.97% 27

Other funds holding AMGN

Wilmington Savings Fund Society's AMGN Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its Amgen (AMGN) stake by 2.5% in Q2 2026, selling an estimated $410K and leaving 47,244 shares worth $17.1M. The position accounts for 0.38% of the portfolio, ranked #60.

Wilmington Savings Fund Society first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.2M in Q4 2014. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wilmington Savings Fund Society held 47,244 shares of Amgen worth $17.1M as of Q2 2026.
  • Wilmington Savings Fund Society sold 1,199 Amgen shares in Q2 2026, an estimated $410K.
  • Amgen made up 0.38% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #60 holding.
  • Wilmington Savings Fund Society first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Wilmington Savings Fund Society's Amgen position peaked at $23.2M in Q4 2014.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.